(Q44437918)

English

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation (English)

1 reference

10.1016/S0041-1345(03)00353-1

https://api.crossref.org/works/10.1016/S0041-1345(03)00353-1

1 January 2024

phase III clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0041-1345(03)00353-1

https://api.crossref.org/works/10.1016/S0041-1345(03)00353-1

1 January 2024

author name string

B. D. Kahan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742466

1 January 2024

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0041134503003531?httpAccept=text/xml

1 reference

10.1016/S0041-1345(03)00353-1

https://api.crossref.org/works/10.1016/S0041-1345(03)00353-1

1 January 2024

https://api.elsevier.com/content/article/PII:S0041134503003531?httpAccept=text/plain

1 reference

10.1016/S0041-1345(03)00353-1

https://api.crossref.org/works/10.1016/S0041-1345(03)00353-1

1 January 2024

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

3 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

37S-51S

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

P-glycoprotein and drug therapy in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Median effect analysis of efficacy versus adverse effects of immunosuppressants

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus improves the two-year outcome of renal allografts in African-American patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900353-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0041-1345(03)00353-1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44437918&oldid=2042453400"